Back
Speaker illustration

Doctor Jonas Silverdal

Sahlgrenska University Hospital, Gothenburg (Sweden)

Member of:

European Society of Cardiology

Presentations

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Precision medicine in hypertrophic cardiomyopathy

Access
Like
Thumbnail

Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertrophic cardiomyopathy (1)

Access
Like
Thumbnail

Mortality and prognostic factors in dilated cardiomyopathy versus ischaemic heart disease in patients with heart failure with reduced ejection fraction - a Swedish population-based study

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Obesity in Heart Failure

Access
Like
Thumbnail

Prognostic impact of ischemic heart disease in heart failure, and its trend over time

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure – epidemiology, prognosis, outcome

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources